AU2001270894A1 - Improvements relating to vaccines containing bordetella pertussis antigen - Google Patents

Improvements relating to vaccines containing bordetella pertussis antigen

Info

Publication number
AU2001270894A1
AU2001270894A1 AU2001270894A AU7089401A AU2001270894A1 AU 2001270894 A1 AU2001270894 A1 AU 2001270894A1 AU 2001270894 A AU2001270894 A AU 2001270894A AU 7089401 A AU7089401 A AU 7089401A AU 2001270894 A1 AU2001270894 A1 AU 2001270894A1
Authority
AU
Australia
Prior art keywords
improvements relating
bordetella pertussis
vaccines containing
pertussis antigen
containing bordetella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270894A
Inventor
Annette Maria Crowley-Luke
Andrew Richard Gorringe
Michael John Hudson
Karen Margaret Reddin
Andrew Robinson
Margaret Alison Sims
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiological Research Authority
Original Assignee
Microbiological Research Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Research Authority filed Critical Microbiological Research Authority
Publication of AU2001270894A1 publication Critical patent/AU2001270894A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001270894A 2000-07-21 2001-07-20 Improvements relating to vaccines containing bordetella pertussis antigen Abandoned AU2001270894A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018031 2000-07-21
GBGB0018031.5A GB0018031D0 (en) 2000-07-21 2000-07-21 Improvements relating to vaccines containing bordetella pertussis antigen
PCT/GB2001/003273 WO2002007764A1 (en) 2000-07-21 2001-07-20 Improvements relating to vaccines containing bordetella pertussis antigen

Publications (1)

Publication Number Publication Date
AU2001270894A1 true AU2001270894A1 (en) 2002-02-05

Family

ID=9896159

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270894A Abandoned AU2001270894A1 (en) 2000-07-21 2001-07-20 Improvements relating to vaccines containing bordetella pertussis antigen

Country Status (3)

Country Link
AU (1) AU2001270894A1 (en)
GB (1) GB0018031D0 (en)
WO (1) WO2002007764A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2863943T3 (en) 2013-03-08 2016-11-07 Janssen Vaccines & Prevention Bv acellular pertussis vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713156D0 (en) * 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines

Also Published As

Publication number Publication date
WO2002007764A1 (en) 2002-01-31
GB0018031D0 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
AP2002002700A0 (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
GB0020089D0 (en) Vaccine Composition
HUP0301092A3 (en) Vaccine
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
AU2001255196A1 (en) Compositions and methods for enhancing immunogenicity of antigens
AU4433702A (en) Vaccines
AU1084901A (en) Dna vaccines encoding antigen linked to a domain that binds cd40
AU2001258279A1 (en) Adjuvant for vaccines
AU1591402A (en) Vaccine
AU8207301A (en) Purification of hbv antigens for use in vaccines
AU2001267707A1 (en) Antiperspirant formulations
GB0014288D0 (en) Vaccine
AU2001267693A1 (en) Antiperspirant formulations
AU2001270894A1 (en) Improvements relating to vaccines containing bordetella pertussis antigen
AU2001267541A1 (en) Vaccine composition
AU2152002A (en) Vaccine composition containing transforming growth factor alpha
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
AU2002214938A1 (en) Method for obtaining antigenic structures enhancing specific cross reactivity
AU7112401A (en) Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
GB0025694D0 (en) Vaccine
AU2002222139A1 (en) Hcv vaccines
AU2001266534A1 (en) Papillomavirus vaccine
GB0015722D0 (en) Vaccine